Ratings by Mizuho (Irina Koffler)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/6/2019 | Mallinckrodt plc | MNK | Maintain | Neutral (N/A) |
|
Details | ||
| 7/30/2019 | Mylan | MYL | Maintain | Neutral (N/A) |
|
Details | ||
| 7/29/2019 | Mylan | MYL | Maintain | Neutral (N/A) |
|
Details | ||
| 7/3/2019 | Jazz Pharmaceuticals | JAZZ | Maintain | Neutral (Neutral) |
|
Details | ||
| 6/26/2019 | Allergen | AGN | Downgrade | Neutral (Outperform) |
129.57 (193.02) |
48.97% | Details | |
| 6/25/2019 | Allergen | AGN | Maintain | Outperform (N/A) |
|
Details | ||
| 6/20/2019 | Bausch Health Companies | BHC | Maintain | Outperform (N/A) |
|
Details | ||
| 6/17/2019 | Teva Pharma | TEVA | Maintain | Neutral (N/A) |
|
Details | ||
| 6/10/2019 | Horizon Pharma | HZNP | Maintain | Neutral (N/A) |
|
Details | ||
| 6/6/2019 | Dermira | DERM | Upgrade | Outperform (Neutral) |
9.38 (8.06) |
-14.07% | Details | |
| 5/28/2019 | Mallinckrodt plc | MNK | Maintain | Neutral (N/A) |
|
Details | ||
| 5/20/2019 | Evolus | EOLS | Maintain | Outperform (N/A) |
|
Details | ||
| 5/17/2019 | Supernus Pharmaceuticals | SUPN | Maintain | Outperform (N/A) |
|
Details | ||
| 5/14/2019 | Mylan | MYL | Maintain | Neutral (N/A) |
|
Details | ||
| 5/7/2019 | Bausch Health Companies | BHC | Maintain | Outperform (N/A) |
|
Details | ||
| 5/6/2019 | Pacira Pharmaceuticals | PCRX | Upgrade | Neutral (Underperform) |
47.93 (23.70) |
-50.55% | Details | |
| 5/3/2019 | Ironwood Pharmaceuticals | IRWD | Maintain | Outperform (N/A) |
|
Details | ||
| 5/1/2019 | Pacira Pharmaceuticals | PCRX | Maintain | Underperform (N/A) |
|
Details | ||
| 4/10/2019 | Bausch Health Companies | BHC | Maintain | Outperform (N/A) |
|
Details | ||
| 4/8/2019 | Endo International plc | ENDP | Maintain | Neutral (N/A) |
|
Details | ||
| 3/29/2019 | Mallinckrodt plc | MNK | Maintain | Neutral (N/A) |
|
Details | ||
| 3/28/2019 | Supernus Pharmaceuticals | SUPN | Maintain | Outperform (N/A) |
|
Details | ||
| 3/27/2019 | Jazz Pharmaceuticals | JAZZ | Maintain | Neutral (N/A) |
|
Details | ||
| 3/22/2019 | Eagle Pharmaceuticals | EGRX | Maintain | Neutral (N/A) |
|
Details | ||
| 3/20/2019 | Dermira | DERM | Maintain | Neutral (N/A) |
|
Details | ||
| 3/19/2019 | Evolus | EOLS | Maintain | Outperform (N/A) |
|
Details | ||
| 3/18/2019 | Dermira | DERM | Maintain | Neutral (N/A) |
|
Details | ||
| 3/18/2019 | Bausch Health Companies | BHC | Maintain | Outperform (N/A) |
|
Details | ||
| 3/7/2019 | Dermira | DERM | Maintain | Neutral (Neutral) |
|
Details | ||
| 3/6/2019 | Pacira Pharmaceuticals | PCRX | Maintain | Underperform (N/A) |
|
Details | ||
| 3/5/2019 | Adamas Pharmaceuticals | ADMS | Downgrade | Underperform (Neutral) |
12.15 (8.22) |
-32.35% | Details | |
| 3/1/2019 | Horizon Pharma | HZNP | Maintain | Neutral (N/A) |
|
Details | ||
| 2/28/2019 | Mallinckrodt plc | MNK | Maintain | Neutral (N/A) |
|
Details | ||
| 2/22/2019 | Ironwood Pharmaceuticals | IRWD | Maintain | Outperform (N/A) |
|
Details | ||
| 2/4/2019 | Jazz Pharmaceuticals | JAZZ | Maintain | Neutral (N/A) |
|
Details | ||
| 2/1/2019 | Pacira Pharmaceuticals | PCRX | Downgrade | Underperform (Neutral) |
40.80 (23.70) |
-41.91% | Details | |
| 1/30/2019 | Allergen | AGN | Maintain | Outperform (Outperform) |
|
Details | ||
| 1/15/2019 | Ironwood Pharmaceuticals | IRWD | Maintain | Outperform (N/A) |
|
Details | ||
| 12/17/2018 | Supernus Pharmaceuticals | SUPN | Maintain | Outperform (Outperform) |
|
Details | ||
| 12/17/2018 | Mallinckrodt plc | MNK | Maintain | Neutral (Neutral) |
|
Details | ||
| 12/12/2018 | Bausch Health Companies | BHC | Maintain | Outperform (N/A) |
|
Details | ||
| 11/30/2018 | Bausch Health Companies | BHC | Maintain | Outperform (Outperform) |
|
Details | ||
| 11/30/2018 | Assertio Therapeutics | ASRT | Downgrade | Neutral (Outperform) |
5.28 (23.50) |
345.08% | Details | |
| 11/26/2018 | Endo International plc | ENDP | Maintain | Neutral (Neutral) |
|
Details | ||
| 11/20/2018 | Jazz Pharmaceuticals | JAZZ | Maintain | Neutral (N/A) |
|
Details | ||
| 11/19/2018 | Ironwood Pharmaceuticals | IRWD | Maintain | Outperform (N/A) |
|
Details | ||
| 11/15/2018 | Horizon Pharma | HZNP | Downgrade | Neutral (Outperform) |
21.85 (116.30) |
432.27% | Details | |
| 11/13/2018 | Mallinckrodt plc | MNK | Maintain | Neutral (N/A) |
|
Details | ||
| 11/7/2018 | Eagle Pharmaceuticals | EGRX | Maintain | Neutral (N/A) |
|
Details | ||
| 11/6/2018 | Mylan | MYL | Maintain | Neutral (N/A) |
|
Details | ||
| 11/6/2018 | Evolus | EOLS | Maintain | Outperform (Outperform) |
|
Details | ||
| 11/5/2018 | Pacira Pharmaceuticals | PCRX | Maintain | Neutral (Neutral) |
|
Details | ||
| 11/5/2018 | Adamas Pharmaceuticals | ADMS | Downgrade | Neutral (Outperform) |
16.97 (12.15) |
-28.4% | Details | |
| 10/31/2018 | Ironwood Pharmaceuticals | IRWD | Maintain | Outperform (Outperform) |
|
Details | ||
| 10/15/2018 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 10/12/2018 | Endo International plc | ENDP | Maintain | Neutral (N/A) |
|
Details | ||
| 10/8/2018 | Horizon Pharma | HZNP | Maintain | Outperform (N/A) |
|
Details | ||
| 10/8/2018 | Bausch Health Companies | BHC | Maintain | Outperform (N/A) |
|
Details | ||
| 10/5/2018 | Mylan | MYL | Downgrade | Neutral (Outperform) |
36.03 (15.86) |
-55.98% | Details | |
| 9/18/2018 | Supernus Pharmaceuticals | SUPN | New Coverage | Outperform (N/A) |
48.05 (47.09) |
-2% | Details | |
| 9/17/2018 | Teva Pharma | TEVA | Maintain | Outperform (N/A) |
|
Details | ||
| 9/12/2018 | Bausch Health Companies | BHC | Maintain | Outperform (N/A) |
|
Details | ||
| 8/22/2018 | Bausch Health Companies | BHC | Maintain | Outperform (N/A) |
|
Details | ||
| 8/17/2018 | Adamas Pharmaceuticals | ADMS | Maintain | Outperform (N/A) |
|
Details | ||
| 8/17/2018 | Eagle Pharmaceuticals | EGRX | Maintain | Neutral (N/A) |
|
Details | ||
| 8/16/2018 | Mylan | MYL | Maintain | Outperform (Outperform) |
|
Details | ||
| 8/14/2018 | Endo International plc | ENDP | Maintain | Neutral (N/A) |
|
Details |
